←Back to Expert Scholars
Translational Medicine / 转化医学Hodgkin Lymphoma
John Radford
MD
🏢University of Manchester🌐UK
Professor of Medical Oncology
80
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
John Radford led the RATHL and RAPID trials that established PET-adapted approaches in advanced and early-stage Hodgkin lymphoma and supported safe omission of bleomycin and radiotherapy in selected patients. He shaped UK and international Hodgkin practice.
Share:
🧪Research Fields 研究领域
RATHL trial
PET-adapted therapy
early-stage Hodgkin lymphoma
RAPID trial
radiation de-escalation
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 John Radford 的研究动态
Follow John Radford's research updates
留下邮箱，当我们发布与 John Radford（University of Manchester）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment